컴피턴트 셀 시장 규모, 점유율, 성장 분석 : 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Competent Cells Market Size, Share, Growth Analysis, By Type (Chemically Competent Cells, Electrocompetent Cells), By Application (Cloning, Subcloning & Routine Cloning), By End User, By Region - Industry Forecast 2025-2032
상품코드:1624022
리서치사:SkyQuest
발행일:2025년 01월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 컴피턴트 셀 시장 규모는 2023년에 21억 3,000만 달러로 평가되며, 예측 기간(2025-2032년)의 CAGR은 8.1%로, 2024년 23억 달러에서 2032년에는 42억 9,000만 달러로 성장할 전망입니다.
세계의 컴피턴트 셀 시장은 분자 클로닝 연구에 대한 공공 및 민간 부문의 투자 증가로 인해 크게 성장하고 있습니다. 대장균은 염화칼슘과 열충격과 같은 기술을 통해 염색체 외 DNA를 통합하는 독특한 능력을 가지고 있으며, 연구자들에게 매력적입니다. 이러한 방법은 투과성 세포벽을 만들어 다양한 용도에 필수적인 DNA 형질전환을 용이하게 합니다. 또한 의료비 지출 증가와 이러한 솔루션에 대한 인식이 높아지면서 분자 복제 제품에 대한 소비자 수요가 증가함에 따라 시장 확대가 더욱 가속화되고 있습니다. 연구 자금과 인구 증가를 지원하기 위한 정부의 구상도 시장 역학에 긍정적으로 기여하고 있으며, 이는 유능한 세포 기술의 혁신과 개발을 위한 견고한 환경을 지원하고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
기술 분석
규제 분석
특허 분석
사례 연구
컴피턴트 셀 시장 규모 : 유형별
시장 개요
화학적 컴피턴트 셀
일렉트로컴피턴트 셀
컴피턴트 셀 시장 규모 : 용도별
시장 개요
클론
서브 클로닝과 루틴 클로닝
파지 디스플레이 라이브러리 구축
유독/불안정 DNA 클로닝
하이스루풋(High throughput) 클로닝
단백질 발현
기타 용도
돌연변이 유발
외가닥 DNA 생성
렌티바이러스 벡터 생산
큰 플라스미드 변환
컴피턴트 셀 시장 규모 : 최종사용자별
시장 개요
제약·바이오테크놀러지 기업
학술 조사기관
계약 조사기관(CRO)
컴피턴트 셀 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Merck KGaA(Germany)
Promega Corporation(US)
Thermo Fisher Scientific, Inc.(US)
New England Biolabs(US)
Takara Bio(Japan)
Agilent Technologies(US)
Lucigen(Epicenter)(Illumina)(US)
QIAGEN N.V.(Germany)
OriGene Technologies(US)
Bioline(UK)
Zymo Research(US)
Beijing TransGen Biotech Co., Ltd.(China)
Source BioScience(UK)
IBA GmbH(Germany)
Genewiz(US)
BioDynamics Laboratory, Inc.(Japan)
GCC Biotech(India)
SMOBIO Technology(Taiwan)
GeneScript Corporation(US)
Bio-Rad Laboratories(US)
결론과 권장사항
KSA
영문 목차
영문목차
Global Competent Cells Market size was valued at USD 2.13 billion in 2023 and is poised to grow from USD 2.3 billion in 2024 to USD 4.29 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).
The global competent cells market is experiencing significant growth, driven by increased investments from both public and private sectors in molecular cloning research. E. coli's unique ability to integrate extrachromosomal DNA through techniques involving calcium chloride and heat shock is compelling for researchers. These methods create permeable cell walls, facilitating DNA transformation essential for various applications. Additionally, rising consumer demand for molecularly cloned products, coupled with growing healthcare expenditures and heightened awareness of these solutions, further bolsters market expansion. Government initiatives supporting research funding and population growth also contribute positively to the market's dynamics, underscoring a robust environment for innovation and development in competent cell technologies.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Competent Cells market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Competent Cells Market Segmental Analysis
Global Competent Cells Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into Chemically Competent Cells and Electrocompetent Cells. Based on Application, the market is segmented into Cloning, Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, High-throughput Cloning, Protein Expression, Other Applications, Mutagenesis, Single-stranded DNA Production, Lentiviral Vector Production and Large Plasmid Transformation. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Competent Cells Market
The global competent cells market is poised for growth, largely propelled by favorable government initiatives and the surging demand for products developed through recombinant DNA technology, alongside advancements in molecular engineering. Over the coming years, this market is expected to thrive due to heightened research and development efforts aimed at creating therapeutic items addressing various health conditions, coupled with beneficial reimbursement and regulatory frameworks. Furthermore, a growing commercial interest in molecularly cloned products and recombinant proteins, alongside increased government investment in research activities, is anticipated to significantly enhance market potential throughout the next decade.
Restraints in the Global Competent Cells Market
The Global Competent Cells market is likely to face several constraints hindering its growth. One significant factor is the high cost associated with competent cell kits, which can deter potential market entrants and limit accessibility for smaller research facilities. Furthermore, the increasing market consolidation is raising entry barriers, making it challenging for new players to compete. Compounding these issues, a shortage of skilled professionals with expertise in this field is expected to pose an additional challenge during the forecast period, ultimately impeding the overall expansion of the competent cells market.
Market Trends of the Global Competent Cells Market
The Global Competent Cells market is poised for significant growth, driven by the rising demand for molecular cloning applications across various sectors. Increasing investments in cloning research, coupled with financial support from governmental and private organizations, are propelling advancements in cell engineering techniques like somatic cell nuclear transfer (SCNT). These technologies are pivotal in producing transgenic animals, preserving endangered species, and advancing therapeutic cloning. As competent cells play a crucial role in these innovative research areas, the market is expected to attract renewed interest and investment, resulting in a robust upward trend in demand for competent cells worldwide.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies
Global Competent Cells Market Size by Type & CAGR (2025-2032)
Market Overview
Chemically Competent Cells
Electrocompetent Cells
Global Competent Cells Market Size by Application & CAGR (2025-2032)
Market Overview
Cloning
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-throughput Cloning
Protein Expression
Other Applications
Mutagenesis
Single-stranded DNA Production
Lentiviral Vector Production
Large Plasmid Transformation
Global Competent Cells Market Size by End User & CAGR (2025-2032)
Market Overview
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Contract Research Organizations (CROs)
Global Competent Cells Market Size & CAGR (2025-2032)
North America (Type, Application, End User)
US
Canada
Europe (Type, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Type, Application, End User)
